Antibodies causing thrombocytopenia in patients treated with RGD-mimetic platelet inhibitors recognize ligand-specific conformers of α IIb/β3 integrin

Blood

Volumn 119, Issue 26, 2012, Pages 6317-6325

  Bougie, Daniel W ^a   Rasmussen, Mark ^a   Zhu, Jieqing ^a   Aster, Richard H ^a,b  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ARGINYLGLYCYLASPARTIC ACID; ARGINYLGLYCYLASPARTYLTRYPTOPHAN; EPITOPE; EPTIFIBATIDE; FIBRINOGEN RECEPTOR; FIBRINOGEN RECEPTOR ANTAGONIST; LIGAND; MONOCLONAL ANTIBODY; ORBOFIBAN; SYNTHETIC PEPTIDE; TIROFIBAN; UNCLASSIFIED DRUG; XEMILOFIBAN;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; BINDING SITE; CHEMICAL STRUCTURE; CLINICAL ARTICLE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTOPENIA; X RAY CRYSTALLOGRAPHY;

EID: 84863510984     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-01-406322     Document Type: Article

References (47)

1. Coller BS. Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics. J Clin Invest. 1997;100(11 Suppl):S57-S60. (Pubitemid 28009548)
2. Topol EJ, Byzova TV, Plow EF. Platelet GPIIb-IIIa blockers. Lancet. 1999;353(9148):227-231. (Pubitemid 29088046)
3. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis. Circulation. 1997;96(5):1445-1453.
4. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. The PURSUIT Trial Investigators. Platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy. N Engl J Med. 1998;339(7):436-443.
5. Aster RH. Immune thrombocytopenia caused by glycoprotein IIb/IIIa inhibitors. Chest. 2005;127(2 Suppl):53S-59S. (Pubitemid 40224082)
6. Bednar B, Cook JJ, Holahan MA, et al. Fibrinogen receptor antagonist-induced thrombocytopenia in chimpanzee and rhesus monkey associated with preexisting drug-dependent antibodies to platelet glycoprotein IIb/IIIa. Blood. 1999;94(2):587-599. (Pubitemid 29323873)
7. Bougie DW, Wilker PR, Wuitschick ED, et al. Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa. Blood. 2002;100(6):2071-2076. (Pubitemid 35001239)
8. Brassard JA, Curtis BR, Cooper RA, et al. Acute thrombocytopenia in patients treated with the oral glycoprotein IIb/IIIa inhibitors xemilofiban and orbofiban: evidence for an immune etiology. Thromb Haemost. 2002;88(6):892-897. (Pubitemid 36018772)
9. Dunkley S, Lindeman R, Evans S, Casten R, Jepson N. Evidence of platelet activation due to tirofiban-dependent platelet antibodies: double trouble. J Thromb Haemost. 2003;1(10):2248-2250.
10. Billheimer JT, Dicker IB, Wynn R, et al. Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediated. Blood. 2002;99(10):3540-3546. (Pubitemid 34534520)
11. Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. N Engl J Med. 2007;357(6):580-587. (Pubitemid 47236283)
12. Aster RH, Curtis BR, McFarland JG, Bougie DW. Drug-induced immune thrombocytopenia: pathogenesis, diagnosis and management. J Thromb Haemost. 2009;7(6):911-918.
13. Christie DJ, Aster RH. Drug-antibody-platelet interaction in quinine- and quinidine-induced thrombocytopenia. J Clin Invest. 1982;70(5):989-998. (Pubitemid 13254922)
14. Asvadi P, Ahmadi Z, Chong BH. Drug-induced thrombocytopenia: localization of the binding site of GPIX-specific quinine-dependent antibodies. Blood. 2003;102(5):1670-1677. (Pubitemid 37022559)
15. Shulman NR, Reid DM. Mechanisms of drug-induced immunologically mediated cytopenias. Transfus Med Rev. 1993;7(4):215-229. (Pubitemid 23297286)
16. Bougie DW, Wilker PR, Aster RH. Patients with quinine-induced immune thrombocytopenia have both "drug-dependent" and "drug- specific" antibodies. Blood. 2006;108(3):922-927. (Pubitemid 44154626)
17. Xiao T, Takagi J, Coller BS, Wang JH, Springer TA. Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature. 2004;432(7013):59-67. (Pubitemid 39490825)
18. Luo BH, Carman CV, Springer TA. Structural basis of integrin regulation and signaling. Annu Rev Immunol. 2007;25:619-647. (Pubitemid 46697919)
19. Zhu J, Luo BH, Xiao T, Zhang C, Nishida N, Springer TA. Structure of a complete integrin ectodomain in a physiologic resting state and activation and deactivation by applied forces. Mol Cell. 2008;32(6):849-861.
20. Zhu J, Negri A, Provasi D, Filizola M, Coller BS, Springer TA. Closed headpiece of integrin alphaIIbbeta3 and its complex with an alphaIIbbeta3- specific antagonist that does not induce opening. Blood. 2010;116(23):5050-5059.
21. Frelinger AL, III, Du XP, Plow EF, Ginsberg MH. Monoclonal antibodies to ligand-occupied conformers of integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) alter receptor affinity, specificity, and function. J Biol Chem. 1991;266(26):17106-17111. (Pubitemid 21907912)
22. Kouns WC, Newman PJ, Puckett KJ, et al. Further characterization of the loop structure of platelet glycoprotein IIIa: partial mapping of functionally significant glycoprotein IIIa epitopes. Blood. 1991;78(12):3215-3223.
23. Du X, Gu M, Weisel JW, et al. Long range propagation of conformational changes in integrin alpha IIb beta 3. J Biol Chem. 1993;268(31):23087-23092. (Pubitemid 23328016)
24. Honda S, Tomiyama Y, Pelletier AJ, et al. Topography of ligand-induced binding sites, including a novel cation-sensitive epitope (AP5) at the amino terminus, of the human integrin beta 3 subunit. J Biol Chem. 1995;270(20):11947-11954.
25. Abrams CS, Cines DB. Thrombocytopenia after treatment with platelet glycoprotein IIb/IIIa inhibitors. Curr Hematol Rep. 2004;3(2):143-147.
26. Brassard JA, Correa R, Kupfer SR, et al. Acute thrombocytopenia after treatment with the oral fibrinogen receptor antagonist xemilofiban: clinical presentation and evidence for an immune etiology. Blood. 1999;94(Suppl 1):647a.
27. Fitzgerald LA, Leung B, Phillips DR. A method for purifying the platelet membrane glycoprotein IIb-IIIa complex. Anal Biochem. 1985;151(1):169-177. (Pubitemid 16155021)
28. Bougie DW, Birenbaum J, Rasmussen M, Poncz M, Aster RH. Quinine-dependent, platelet-reactive monoclonals mimic antibodies found in patients with quinine-induced immune thrombocytopenia. Blood. 2009;113(5):1105-1111.
29. Kouns WC, Wall CD, White MM, Fox CF, Jennings LK. A conformation- dependent epitope of human platelet glycoprotein IIIa. J Biol Chem. 1990;265(33):20594-20601. (Pubitemid 120014049)
30. Loftus JC, Plow EF, Frelinger AL III, et al. Molecular cloning and chemical synthesis of a region of platelet glycoprotein IIb involved in adhesive function. Proc Natl Acad Sci U S A. 1987;84(20):7114-7118. (Pubitemid 18017320)
31. Artoni A, Li J, Mitchell B, et al. Integrin beta3 regions controlling binding of murine mAb 7E3: implications for the mechanism of integrin alphaIIbbeta3 activation. Proc Natl Acad Sci U S A. 2004;101(36):13114-13120. (Pubitemid 39209628)
32. Peterson JA, Nyree CE, Newman PJ, Aster RH. A site involving the "hybrid" and PSI homology domains of GPIIIa (beta 3-integrin subunit) is a common target for antibodies associated with quinine-induced immune thrombocytopenia. Blood. 2003;101(3):937-942. (Pubitemid 36139362)
33. Puzon-McLaughlin W, Kamata T, Takada Y. Multiple discontinuous ligand-mimetic antibody binding sites define a ligand binding pocket in integrin alpha(IIb)beta(3). J Biol Chem. 2000;275(11):7795-7802. (Pubitemid 30159685)
34. Davies DR, Padlan EA, Sheriff S. Antibody-antigen complexes. Annu Rev Biochem. 1990;59:439-473.
35. Sundberg EJ, Mariuzza RA. Molecular recognition in antibody-antigen complexes. Adv Protein Chem. 2002;61:119-160. (Pubitemid 35303456)
36. Lo Conte L, Chothia C, Janin J. The atomic structure of protein-protein recognition sites. J Mol Biol. 1999;285(5):2177-2198. (Pubitemid 29078179)
37. Takagi J, Petre BM, Walz T, Springer TA. Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling. Cell. 2002;110(5):599-611. (Pubitemid 35247840)
38. Beglova N, Blacklow SC, Takagi J, Springer TA. Cysteine-rich module structure reveals a fulcrum for integrin rearrangement upon activation. Nat Struct Biol. 2002;9(4):282-287. (Pubitemid 34289901)
39. Luo BH, Strokovich K, Walz T, Springer TA, Takagi J. Allosteric beta1 integrin antibodies that stabilize the low affinity state by preventing the swing-out of the hybrid domain. J Biol Chem. 2004;279(26):27466-27471. (Pubitemid 38812586)
40. Luo BH, Takagi J, Springer TA. Locking the beta3 integrin I-like domain into high and low affinity conformations with disulfides. J Biol Chem. 2004;279(11):10215-10221. (Pubitemid 38372626)
41. Blue R, Li J, Steinberger J, Murcia M, Filizola M, Coller BS. Effects of limiting extension at the alphaIIb genu on ligand binding to integrin alphaIIbbeta3. J Biol Chem. 2010;285(23):17604-17613.
42. Mousa SA, Bozarth JM, Naik UP, Slee A. Platelet GPIIb/IIIa binding characteristics of small molecule RGD mimetic: distinct binding profile for Roxifiban. Br J Pharmacol. 2001;133(3):331-336. (Pubitemid 33027768)
43. Jennings LK, Haga JH, Slack SM. Differential expression of a ligand induced binding site (LIBS) by GPIIb-IIIa ligand recognition peptides and parenteral antagonists. Thromb Haemost. 2000;84(6):1095-1102. (Pubitemid 32014047)
44. Peterson JA, Nelson TN, Kanack AJ, Aster RH. Fine specificity of drug-dependent antibodies reactive with a restricted domain of platelet GPIIIA. Blood. 2008;111(3):1234-1239. (Pubitemid 351213405)
45. Xiong JP, Stehle T, Diefenbach B, et al. Crystal structure of the extracellular segment of integrin alpha Vbeta3. Science. 2001;294(5541):339-345. (Pubitemid 32963395)
46. Patel S, Patel M, Din I, Reddy CV, Kassotis J. Profound thrombocytopenia associated with tirofiban: case report and review of literature. Angiology. 2005;56(3):351-355. (Pubitemid 40656442)
47. Coons JC, Barcelona RA, Freedy T, Hagerty MF. Eptifibatide-associated acute, profound thrombocytopenia. Ann Pharmacother. 2005;39(2):368-372. (Pubitemid 40165232)